Source:
Medical education online [Med Educ Online] 2024 Dec 31; Vol. 29 (1), pp. 2312716. Date of Electronic Publication: 2024 Feb 15.Publisher: Taylor & Francis Country of Publication: United States NLM ID: 9806550 Publication Model:
Source:
Human vaccines & immunotherapeutics [Hum Vaccin Immunother] 2024 Dec 31; Vol. 20 (1), pp. 2303796. Date of Electronic Publication: 2024 Jan 31.Publisher: Taylor & Francis Country of Publication: United States NLM ID: 101572652 Publication
Authors : Rincon NL; Trinity College of Arts & Sciences, Duke University, Durham, NC, USA.; REACH Equity Summer Undergraduate Research Program (RESURP), Duke University School of Medicine, Durham, NC, USA.
Source:
Human vaccines & immunotherapeutics [Hum Vaccin Immunother] 2024 Dec 31; Vol. 20 (1), pp. 2313249. Date of Electronic Publication: 2024 Mar 27.Publisher: Taylor & Francis Country of Publication: United States NLM ID: 101572652 Publication
Source:
Human vaccines & immunotherapeutics [Hum Vaccin Immunother] 2024 Dec 31; Vol. 20 (1), pp. 2325745. Date of Electronic Publication: 2024 Apr 02.Publisher: Taylor & Francis Country of Publication: United States NLM ID: 101572652 Publication
Source:
Human vaccines & immunotherapeutics [Hum Vaccin Immunother] 2024 Dec 31; Vol. 20 (1), pp. 2327145. Date of Electronic Publication: 2024 Mar 15.Publisher: Taylor & Francis Country of Publication: United States NLM ID: 101572652 Publication
Source:
Human vaccines & immunotherapeutics [Hum Vaccin Immunother] 2024 Dec 31; Vol. 20 (1), pp. 2335722. Date of Electronic Publication: 2024 May 03.Publisher: Taylor & Francis Country of Publication: United States NLM ID: 101572652 Publication
Source:
Human vaccines & immunotherapeutics [Hum Vaccin Immunother] 2024 Dec 31; Vol. 20 (1), pp. 2358566. Date of Electronic Publication: 2024 Jun 07.Publisher: Taylor & Francis Country of Publication: United States NLM ID: 101572652 Publication
Authors : Parker CE; Immunization Safety Office, Division of Healthcare Quality Promotion, National Center for Emerging and Zoonotic Infectious Diseases, Centers for Disease Control and Prevention, Atlanta, GA, USA.; ORISE Health Studies Program, Oak Ridge Associated Universities, Oak Ridge, TN, USA.
Source:
Human vaccines & immunotherapeutics [Hum Vaccin Immunother] 2024 Dec 31; Vol. 20 (1), pp. 2361946. Date of Electronic Publication: 2024 Jun 07.Publisher: Taylor & Francis Country of Publication: United States NLM ID: 101572652 Publication